Table 2. . Best objective response to treatment by RECIST 1.1 of 100 patients after use of immunotherapy.
| Objective response rate | Patients, n (%) |
|---|---|
| Complete | 2 (2%) |
| Partial | 11 (11%) |
| Stable disease | 61 (61%) |
| Progressive disease | 4 (4%) |
| Unevaluable | 22 (22%) |